The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Effects of Silver Nanoparticles on Multiple Drug-Resistant Strains of Staphylococcus aureus and Pseudomonas aeruginosa from Mastitis-Infected Goats: An Alternative Approach for Antimicrobial Therapy
Open accessAbstract
Recently, silver nanoparticles (AgNPs) have been widely used in various applications as antimicrobial agents, anticancer, diagnostics, biomarkers, cell labels, and drug delivery systems for the treatment of various diseases. Microorganisms generally acquire resistance to antibiotics through the course of antibacterial therapy. Multi-drug resistance (MDR) has become a growing problem in the treatment of infectious diseases, and the widespread use of broad-spectrum antibiotics has resulted in the development of antibiotic resistance by numerous human and animal bacterial pathogens. As a result, an increasing number of microorganisms are resistant to multiple antibiotics causing continuing economic losses in dairy farming. Therefore, there is an urgent need for the development of alternative, cost-effective, and efficient antimicrobial agents that overcome antimicrobial resistance. Here, AgNPs synthesized using the bio-molecule quercetin were characterized using various analytical techniques. The synthesized AgNPs were highly spherical in shape and had an average size of 11 nm. We evaluated the efficacy of synthesized AgNPs against two MDR pathogenic bacteria, namely, Pseudomonas aeruginosa and Staphylococcus aureus, which were isolated from milk samples produced by mastitis-infected goats. The minimum inhibitory concentrations (MICs) of AgNPs against P. aeruginosa and S. aureus were found to be 1 and 2 μg/mL, respectively. Our findings suggest that AgNPs exert antibacterial effects in a dose- and time-dependent manner. Results from the present study demonstrate that the antibacterial activity of AgNPs is due to the generation of reactive oxygen species (ROS), malondialdehyde (MDA), and leakage of proteins and sugars in bacterial cells. Results of the present study showed that AgNP-treated bacteria had significantly lower lactate dehydrogenase activity (LDH) and lower adenosine triphosphate (ATP) levels compared to the control. Furthermore, AgNP-treated bacteria showed downregulated expression of glutathione (GSH), upregulation of glutathione S-transferase (GST), and downregulation of both superoxide dismutase (SOD) and catalase (CAT). These physiological and biochemical measurements were consistently observed in AgNP-treated bacteria, thereby suggesting that AgNPs can induce bacterial cell death. Thus, the above results represent conclusive findings on the mechanism of action of AgNPs against different types of bacteria. This study also demonstrates the promising use of nanoparticles as antibacterial agents for use in the biotechnology and biomedical industry. Furthermore, this study is the first to propose the mode of action of AgNPs against MDR pathogens isolated from goats infected with subclinical mastitis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“On the basis of these results, Gurunathan and coworkers demonstrated that biosynthesized AgNPs is an effective therapeutic agent for treating mastitis-infected goats in husbandry.”
From Bactericidal and Cytotoxic Properties of Silver Nanoparticles (2019) · cites this paper as [107]
In the citing paper
“The AgNPs exhibited a spherical feature with an average size of 11 nm.”
From Bactericidal and Cytotoxic Properties of Silver Nanoparticles (2019) · cites this paper as [107]
In the citing paper
“The minimum inhibitory concentrations (MICs) of AgNPs against P. aeruginosa and S. aureus were 1 and 2 µg/mL, respectively.”
From Bactericidal and Cytotoxic Properties of Silver Nanoparticles (2019) · cites this paper as [107]
In the citing paper
“The bactericidal effect of AgNPs on bacteria came from the generation of ROS and MDA, and the leakage of proteins and sugars in bacterial cells.”
From Bactericidal and Cytotoxic Properties of Silver Nanoparticles (2019) · cites this paper as [107]
In the citing paper
“Complete growth inhibition concentration and time were determined to be 1 μg/mL AgNPs and 20 h for P. aeruginosa, while those for S. aureus were 2 μg/mL and 24 h, respectively.”
From Bactericidal and Cytotoxic Properties of Silver Nanoparticles (2019) · cites this paper as [107]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952
Staphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,005
Sondi, I., & Salopek-Sondi, B. (2004) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2004.02.012 · Cited by 5,986
[42] Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal
Esterbauer, H., & Cheeseman, K. H. (1990) · Methods in Enzymology · doi:10.1016/0076-6879(90)86134-h · Cited by 3,345
A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics
Kohanski, M. A., Dwyer, D. J., Hayete, B., Lawrence, C. A., & Collins, J. J. (2007) · Cell · doi:10.1016/j.cell.2007.06.049 · Cited by 2,982 · cited 1×
“For instance, various types of antibiotics, including aminoglycosides, β-lactams, and fluoroquinolones, induce ROS generation in bacteria and consequently lead to loss of cell viability [62,63].”
BackgroundSilver as Antibacterial Agent: Ion, Nanoparticle, and Metal
Chernousova, S., & Epple, M. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201205923 · Cited by 2,264
Marnett, L. J. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.361 · Cited by 1,883
Carlson, C., Hussain, S. M., Schrand, A. M., K. Braydich-Stolle, L., Hess, K. L., Jones, R. L., & Schlager, J. J. (2008) · The Journal of Physical Chemistry B · doi:10.1021/jp712087m · Cited by 1,814
Oxidative Stress, Prooxidants, and Antioxidants: The Interplay
Rahal, A., Kumar, A., Singh, V., Yadav, B., Tiwari, R., Chakraborty, S., & Dhama, K. (2014) · BioMed Research International · doi:10.1155/2014/761264 · Cited by 1,706
Antibacterial activity and mechanism of silver nanoparticles on Escherichia coli
Li, W.-R., Xie, X.-B., Shi, Q.-S., Zeng, H.-Y., OU-Yang, Y.-S., & Chen, Y.-B. (2010) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-009-2159-5 · Cited by 1,697
Cited by
Silver Nanoparticles and Their Antibacterial Applications
Bruna, T., Maldonado-Bravo, F., Jara, P., & Caro, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137202 · Cited by 1,708
Bactericidal and Cytotoxic Properties of Silver Nanoparticles
Liao, C., Li, Y., & Tjong, S. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020449 · Cited by 1,180
Roy, A., Bulut, O., Some, S., Mandal, A. K., & Yilmaz, M. D. (2019) · RSC Advances · doi:10.1039/c8ra08982e · Cited by 1,059
Qing, Y., Cheng, L., Li, R., Liu, G., Zhang, Y., Tang, X., Wang, J., Liu, H., & Qin, Y. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s165125 · Cited by 959
Godoy-Gallardo, M., Eckhard, U., Delgado, L. M., de Roo Puente, Y. J. D., Hoyos-Nogués, M., Gil, F. J., & Perez, R. A. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.04.033 · Cited by 857
Makvandi, P., Wang, C., Zare, E. N., Borzacchiello, A., Niu, L., & Tay, F. R. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201910021 · Cited by 737
A review on the biosynthesis of metal and metal salt nanoparticles by microbes
Gahlawat, G., & Choudhury, A. R. (2019) · RSC Advances · doi:10.1039/c8ra10483b · Cited by 706
Loo, Y. Y., Rukayadi, Y., Nor-Khaizura, M.-A.-R., Kuan, C. H., Chieng, B. W., Nishibuchi, M., & Radu, S. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01555 · Cited by 701
Omerović, N., Djisalov, M., Živojević, K., Mladenović, M., Vunduk, J., Milenković, I., Knežević, N. Ž., Gadjanski, I., & Vidić, J. (2021) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12727 · Cited by 367
Multidrug-Resistant Bacteria and Alternative Methods to Control Them: An Overview
Vivas, R., Barbosa, A. A. T., Dolabela, S. S., & Jain, S. (2019) · Microbial Drug Resistance · doi:10.1089/mdr.2018.0319 · Cited by 343
Tripathi, N., & Goshisht, M. K. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00014 · Cited by 320
Burlec, A. F., Corciova, A., Boev, M., Batir-Marin, D., Mircea, C., Cioanca, O., Danila, G., Danila, M., Bucur, A. F., & Hancianu, M. (2023) · Pharmaceuticals · doi:10.3390/ph16101410 · Cited by 295
Wypij, M., Jędrzejewski, T., Trzcińska-Wencel, J., Ostrowski, M., Rai, M., & Golińska, P. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.632505 · Cited by 291
Barabadi, H., Mojab, F., Vahidi, H., Marashi, B., Talank, N., Hosseini, O., & Saravanan, M. (2021) · Inorganic Chemistry Communications · doi:10.1016/j.inoche.2021.108647 · Cited by 278
An Updated Review on Silver Nanoparticles in Biomedicine
Gherasim, O., Puiu, R. A., Bîrcă, A. C., Burdușel, A.-C., & Grumezescu, A. M. (2020) · Nanomaterials · doi:10.3390/nano10112318 · Cited by 257
Metadata
- Authors
- Yuan, Y.-G., Peng, Q.-L., & Gurunathan, S.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-03-06
- Volume
- 18
- Issue
- 3
- Pages
- 569
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2592103591
- Cited by
- 376
- References
- 69
- FWCI
- 13.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.